Paperpal Prime Logo

npj Parkinson's Disease : Impact Factor & More

eISSN: 2373-8057pISSN: 2373-8057
JournalOpen Access

Key Metrics

CiteScore
9
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
Scite Index
0.91 5-Year SI
SJR
Q1Neurology
SNIP
2.52
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on npj Parkinson's Disease

npj Parkinson's Disease Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher NATURE PORTFOLIO
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2790 | USD 3290 | GBP 2490
Publication Time11
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorParkinson's Foundation
FrequencyContinuous publication
Publication Start Year2015
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in npj Parkinson's Disease ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in npj Parkinson's Disease

Pesticide exposure and multidomain symptom burden in Parkinson\u2019s disease: a longitudinal triangulation study
  • 5 Aug 2026
  • NPJ Parkinson's Disease
Dopamine-related alterations in functional brain network dynamic reconfiguration in Parkinson's disease.
  • 21 Jul 2026
  • NPJ Parkinson's disease
A highly efficient detection model for early-stage Parkinson's disease using non-contact, multi-modality measurement and artificial intelligence.
  • 21 Jul 2026
  • NPJ Parkinson's disease
APCDD1 shows high specificity for ventral midbrain dopaminergic progenitors in a cell surface marker benchmarking study.
  • 20 Jul 2026
  • NPJ Parkinson's disease
Considerations on combination therapies for disease modification in Parkinson's.
  • 17 Jul 2026
  • NPJ Parkinson's disease
Plasma ceramide ratios define metabolic-inflammatory associations with cognitive impairment in Parkinson's disease.
  • 16 Jul 2026
  • NPJ Parkinson's disease
Pesticide exposure and multidomain symptom burden in Parkinson\u2019s disease: a longitudinal triangulation study
  • 5 Aug 2026
  • NPJ Parkinson's Disease
Dopamine-related alterations in functional brain network dynamic reconfiguration in Parkinson's disease.
  • 21 Jul 2026
  • NPJ Parkinson's disease
A highly efficient detection model for early-stage Parkinson's disease using non-contact, multi-modality measurement and artificial intelligence.
  • 21 Jul 2026
  • NPJ Parkinson's disease
APCDD1 shows high specificity for ventral midbrain dopaminergic progenitors in a cell surface marker benchmarking study.
  • 20 Jul 2026
  • NPJ Parkinson's disease
Considerations on combination therapies for disease modification in Parkinson's.
  • 17 Jul 2026
  • NPJ Parkinson's disease
Plasma ceramide ratios define metabolic-inflammatory associations with cognitive impairment in Parkinson's disease.
  • 16 Jul 2026
  • NPJ Parkinson's disease

FAQs on npj Parkinson's Disease